Kiwi to test the resolve of the RBNZ

Its been a month since the August RBNZ MPS meeting (Aug 12) that delivered an extremely dovish commentary and set of policy announcements including an increase in the RBNZ’s quantitative easing (LSAP) program from $60bn to $100bn as well as extending its length from 12 months to 22 months.

Charts (2)

It also provided a discussion of four additional options for the RBNZ to provide further monetary stimulus if needed, including expanding the LSAP program, reducing the OCR below zero, a term lending scheme to banks, and the purchase of foreign assets (such as foreign government bonds).

The purchase of foreign assets is viewed as the option of last resort, despite being highly effective.

How this would work is the RBNZ would create New Zealand dollars to fund the purchase of foreign assets. Thereby putting downward pressure on the exchange rate, via increased New Zealand dollar liquidity and via the direct effect of selling New Zealand dollars. This would result in lower interest rates as well as lower exchange rate, all of which would help the RBNZ to meet its objectives of higher economic activity, inflation, and employment.

While the interest rate market has embraced the idea of negative rates, pricing in almost 50bp of cuts, and taking the OCR to -25bp by the middle of 2021, the exchange rate remains on an upward trajectory, unperturbed by the prospect that the RBNZ may resort to buying foreign assets.

Should the New Zealand exchange rates appreciation accelerate the RBNZ may need to consider making good on its threat to purchase offshore bonds sooner than it may have hoped

Technically the trend of a higher NZDUSD remains in place. After trading to the .6789 high on the 3rd of September, the NZDUSD retraced back to trend line support at .6600c before a rebound commenced, thereby keeping the bullish uptrend intact.

Providing the NZDUSD remains above the aforementioned trendline support and then trades above short term resistance at  .6710ish it would be further confirmation the NZDUSD is set to retest .6800c, along with the resolve of the RBNZ.

Kiwi to test the resolve of the RBNZ

Source Tradingview. The figures stated areas of the 14th of September 2020. Past performance is not a reliable indicator of future performance.  This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.